ArticleEuropean journal of pain (London, England)2026
Development and Internal Validation of a Machine Learning Model for Predicting Long-Term Opioid Therapy After Hip Fracture Surgery in Older, Opioid-Naïve Adults.
Article in European journal of pain (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLong-term opioid therapy (LTOT) after hip fracture surgery is a common postoperative complication associated with adverse outcomes, yet tools to identify at-risk patients among opioid-naïve older adults are lacking. This study aimed to develop and internally validate a parsimonious model to predict LTOT following hip fracture surgery.
methodsUsing Danish nationwide registries, we identified 26,057 opioid-naïve patients (≥ 65 years) undergoing hip fracture surgery (2010-2020) and analysed 29 predictors, covering demographics, comorbidities, medication, lifestyle, socioeconomics and surgical factors. LTOT was defined as redeeming ≥ 2 prescriptions between 31 and 365 days of surgery. Models were developed using four machine learning methods: logistic regression, backwards elimination, elastic net penalised logistic regression and random forest. Model performance was assessed using area under the receiver operating characteristic curve (AUC), calibration slope, intercept, Brier score and decision curve analysis.
resultsLTOT was identified in 8095 (31.1%) patients. The backward elimination algorithm identified the best performing model, selecting 8 of 29 predictors and achieving an AUC of 0.68, calibration slope of 0.99, intercept of 0.02 and Brier score of 0.20. Predictors included age, marital status, preoperative non-opioid pain medication, preoperative novel oral anticoagulants, fracture type, surgery delay, length of hospital stay and postoperative cumulated ambulation score at discharge.
conclusionsA prediction model was developed and validated for use at discharge to identify patients at risk of LTOT 1 year after hip fracture. The model may support risk stratification at discharge, but requires external validation and evaluation of clinical implementation before routine use. SIGNIFICANCE STATEMENT: This study presents the first internally validated prediction model for long-term opioid use in opioid-naïve older adults after hip fracture surgery. The model functions as a simple and interpretable risk stratification tool at discharge and has been incorporated in a freely available risk calculator. It addresses the lack of clinically applicable risk stratification tools in this frail population and highlights opportunities for more targeted postoperative pain management, although feasibility testing is required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.